Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
2 studies found for:    12517020 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia
Conditions: Bacteremia;   Neoplasms
Interventions: Device: Taurolock;   Device: Heparin
2 Completed Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride
Conditions: Catheterization, Central Venous;   Catheter-Associated Infections;   Bacterial Infections;   Bacteremia
Interventions: Drug: 0.1% Octenidine with 30% 1-propanol and 45% 2-propanol;   Drug: 74% Ethanol with 10% 2-propanol
To Top

† Indicates status has not been verified in more than two years